| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 267.607 | 86 |
| GSM780708 | Untreated after 4 days (C2_1) | 257.76 | 86 |
| GSM780709 | Untreated after 4 days (C3_1) | 250.863 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 220.441 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 208.714 | 84 |
| GSM780721 | Untreated after 4 days (C3_2) | 203.51 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 311.461 | 88 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 201.132 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 198.062 | 83 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 189.187 | 83 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 183.696 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 182.096 | 83 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 146.685 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 223.406 | 85 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 207.684 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 144.906 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 175.42 | 82 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 183.386 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 174.853 | 82 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 181.743 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 286.761 | 87 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 166.122 | 82 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 184.22 | 83 |